Age-specific absolute and relative organ weight distributions for B6C3F1 mice

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 75, Issue 2, 2012, Pages 76-99

  Marino, Dale J ^a  

^a Conestoga Rovers and Associates ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRINKING WATER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B6C3F1 MOUSE; BRAIN WEIGHT; CONTROLLED STUDY; FEEDING; FEMALE; GROUPS BY AGE; HEART WEIGHT; INHALATION; KIDNEY MASS; LIVER WEIGHT; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; TESTIS WEIGHT; THYMUS; THYMUS WEIGHT; ANIMAL; BODY WEIGHT; C3H MOUSE; C57BL MOUSE; CROSS BREEDING; GROWTH, DEVELOPMENT AND AGING; HEART; KIDNEY; LIVER; LUNG; NATIONAL HEALTH ORGANIZATION; ORGAN SIZE; REFERENCE VALUE; SEXUAL DEVELOPMENT; TOXICITY TESTING; UNITED STATES;

ANIMALS; BODY WEIGHT; CROSSES, GENETIC; FEMALE; HEART; KIDNEY; LIVER; LUNG; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; NATIONAL CANCER INSTITUTE (U.S.); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES (U.S.); ORGAN SIZE; REFERENCE VALUES; SEX CHARACTERISTICS; TOXICITY TESTS; UNITED STATES;

EID: 84856170852     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287394.2011.625548     Document Type: Article

References (25)

1. Andersen, M. E. 1981. A physiologically-based toxicokinetic description of metabolism of inhaled gases and vapors: analysis at steady state. Toxicol. Appl. Pharmacol., 60: 509-26. (Pubitemid 12194289)
2. Bischoff, K. B. 1987. Physiologically-based pharmacokinetic modeling. In Pharmacokinetics in risk assessment. Drinking water and health, Vol. 8, 36-61. Washington, DC: National Academy Press.
3. Brown, R. P., Delp, M. D., Lindstedt, S. L., Rhomberg, L. R., and, Beliles, R. P. 1997. Physiological parameter values for physiologically based pharmacokinetic models. Toxicol. Ind. Health, 13: 407-84. (Pubitemid 27314117)
4. Clewell, H. J., and, Andersen, M. E. 1985. Risk assessment extrapolations and physiological modeling. Toxicol. Ind. Health, 14: 111-31.
5. Clewell, H. J., and, Andersen, M. E. 1989. Biologically motivated models for chemical risk assessment. Health Phys., 57 (suppl. 1): 129-37. (Pubitemid 20092249)
6. Clewell, H. J., Teeguarden, J., McDonald, T., Sarangapani, R., Lawrence, G., Covington, T., Gentry, R., and, Shipp, A. 2002. Review and evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry. Crit. Rev. Toxicol., 32: 329-89. (Pubitemid 35191357)
7. Cameron, T. P., Hickman, R. L., Kornreich, M. R., and, Tarone, R. E. 1985. History, survival, and growth patterns of B6C3F1 mice and F344 rats in the National Cancer Institute Carcinogenesis Testing Program. Fundam. Appl. Toxicol., 5: 526-38. (Pubitemid 15026304)
8. David, R. M., Clewell, H. J., Gentry, P. R., Covington, T., Morgott, D. A., and, Marino, D. J. 2006. Revised assessment of cancer risk to dichloromethane using improved human metabolic parameters and Bayesian statistics. Regul. Pharmacol. Toxicol., 45: 55-65.
9. Gentry, P. R., Haber, L. T., McDonald, T. B., Zhao, Q., Covington, T., Nance, P., Clewell, H. J., Lipscomb, J. C., and, Barton, H. A. 2004. Data for physiologically based pharmacokinetic modeling in neonatal animals: Physiological parameters in mice and Sprague-Dawley rats. J. Child. Health, 2: 363-411.
10. Gur, E., and, Waner, T. 1993. The variability of organ weight background data in rats. Lab. Anim., 27: 65-72. (Pubitemid 23060214)
11. Haseman, J. K., Bourbina, J., and, Eustis, S. L. 1994. Effect of individual housing and other experimental design factors on tumor incidence in B6C3F1 mice. Fundam. Appl. Toxicol., 23: 44-52. (Pubitemid 24247979)
12. Haseman, J. K., Hailey, J. R., and, Morris, R. W. 1998. Spontaneous neoplasm incidences in Fischer 344 rats and B6C3F1 mice in two-year carcinogenicity studies: A National Toxicology Program update. Toxicol. Pathol., 26: 428-41. (Pubitemid 28224283)
13. Hattis, D., Ginsberg, G., Sonawane, B., Smolenski, S., Russ, A., Kozlak, M., and, Goble, R. 2003. Differences in pharmacokinetics between children and adultsII. Children's variability in drug elimination half-lives and in some parameters needed for physiologically-based pharmacokinetic modeling. Risk Anal., 23: 117-42. (Pubitemid 36255427)
14. Iwata, H., Hagiwara, T., Katoh, M., Yamamoto, S., Yamakawa, S., Shiga, A., Hirouchi, Y., Kobayashi, K., Inoue, H., and, Enomoto, M. 1993. Historical control data of organ weight and gross findings in F344/DuCrj rats and B6C3F1 mice. Jikken Dobutsu, 42: 383-96.
15. Long, G. G., Symanowski, J. T., and, Roback, K. 1998. Precision in data acquisition and reporting of organ weights in rats and mice. Toxicol. Pathol., 26: 316-18. (Pubitemid 28224271)
16. Marino, D. J., Clewell, H. J. I II, Gentry, P. R., Covington, T. R., David, R. M., and, Morgott, D. A. 2006. Bayesian PBPK and dose-response modeling of dichloromethane in mice. Regul. Pharmacol. Toxicol., 45: 44-54.
17. Mirfazaelian, A., and, Fisher, J. W. 2007. Organ growth functions in maturing male Sprague-Dawley rats based on a collective database. J. Toxicol. Environ. Health A, 70: 1052-1063. (Pubitemid 46752499)
18. Mittwoch, U. 1979. Lateral asymmetry of kidney weights in different populations of wild mice. Biol. J. Linn. Soc., 11: 295-300.
19. Rao, G. N., and, Crockett, P. W. 2003. Effect of diet and housing on growth, body weight, survival and tumor incidences of B6C3F1 mice in chronic studies. Toxicol. Pathol., 31: 243-250. (Pubitemid 36374015)
20. Sellers, R. S., Mortan, D., Bindu, M., Roome, N., Johnson, J. K., Yano, B. L., Perry, R., and, Schafer, K. 2007. Society of Toxicologic Pathology position paper: Organ weight recommendations for toxicology studies. Toxicol. Pathol., 35: 751-755.
21. Schoeffner, D. J., Warren, D. A., Muralidara, S., Bruckner, J. V., and, Simmons, J. E. 1999. Organ weights and fat volume in rats as a function of strain and age. J. Toxicol. Environ. Health A, 56: 449-462. (Pubitemid 29178613)
22. Thomas, R. S., Lytle, W. E., Keefe, T. J., Constan, A. A., and, Yang, R. S. 1996a. Incorporating Monte Carlo simulation into physiologically based pharmacokinetic models using advanced continuous simulation language (ACSL): A computational method. Fundam. Appl. Toxicol., 31: 19-28.
23. Thomas, R. S., Yang, R. S., Morgan, D. G., Moorman, M. P., Kermani, H. R., Sloane, R. A., O'Connor, R. W., Adkins, Jr, B., Gargas, M. L., and, Andersen, M. E. 1996b. PBPK modeling/Monte Carlo simulation of methylene chloride kinetic changes in mice in relation to age and acute, subchronic, and chronic inhalation exposure. Environ. Health Perspect., 104: 858-865. (Pubitemid 26319287)
24. U.S. Environmental Protection Agency. 2006. Use of physiologically based pharmacokinetic (PBPK) models to quantify the impact of human age and interindividual differences in physiology and biochemistry pertinent to risk (Final report). U.S. EPA. EPA/600/R-06/014A. http://cfpub.epa.gov/ncea/cfm/ recordisplay.cfm?deid=151384#Download (http://cfpub.epa.gov/ncea/cfm/ recordisplay.cfm?deid=151384#Download) (Accessed: March 2006).
25. Yu, Z. H. 1998. Asymmetrical testicular weights in mammals, birds, reptiles and amphibia. 1998. Int. J. Androl., 21: 53-55.